FLT3 and leukemia: Luteolin possesses selective inhibitory activity against Fms-like tyrosine kinase 3 (FLT3), a receptor tyrosine kinase highly expressed in AML patients, and induces a strong cytotoxic effect in MV4-11 leukemia cells [37].